Edward Gabrielson
Bloomberg (United States)(US)Johns Hopkins University(US)Johns Hopkins Medicine(US)Sidney Kimmel Cancer Center(US)
Publications by Year
Research Areas
Cancer Immunotherapy and Biomarkers, Epigenetics and DNA Methylation, Cancer Genomics and Diagnostics, Radiopharmaceutical Chemistry and Applications, RNA modifications and cancer
Most-Cited Works
- → 5′ CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancers(1995)1,983 cited
- → Dysfunctional KEAP1–NRF2 Interaction in Non-Small-Cell Lung Cancer(2006)1,037 cited
- → Aberrant methylation of p16 INK4a is an early event in lung cancer and a potential biomarker for early diagnosis(1998)960 cited
- → Evolution of Neoantigen Landscape during Immune Checkpoint Blockade in Non–Small Cell Lung Cancer(2016)885 cited
- → Multiple-laboratory comparison of microarray platforms(2005)878 cited
- → A genomic screen for genes upregulated by demethylation and histone deacetylase inhibition in human colorectal cancer(2002)855 cited